Delivery Order SPE2DB24D1034-SPE2DB24FVYH1
Award Date
2/29/24
Potential Completion Date
3/1/24
Potential Value
$8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of 100 tablets of the pharmaceutical drug Repaglinide 1 mg. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $1,609.80 and a period of performance through February 5, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Repaglinide 1 mg tablets, a medication used to manage diabetes, with a ceiling value of $13,095.99 and a period of performance through May 6, 2024. The contract was awarded as a Firm Fixed Price Delivery Order and was not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $6,798.50, is for the delivery of 4,563,575,086 units of the pharmaceutical product Repaglinide 1 mg Tablet in 100-count packages. The contract is a Firm Fixed Price Delivery Order with a completion date of February 7, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major...
This federal contract award, identified as SPE2DB24D1034|SPE2DB25FWAQ2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567321287 units of 1 mg Repaglinide tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,628.82 and a period of performance through February 21, 2025. This award...
The Defense Logistics Agency awarded a $306 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 tablets of 2 mg Repaglinide, an oral anti-diabetic medication. To be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania, the order is valued at three hundred six dollars and twelve cents exactly and runs from July 31, 2023 through August 1, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense,...
<p>Defense Logistics Agency awarded a $961 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 tablets of 2 mg repaglinide, to be delivered by October 19, 2023. The order was placed under an existing contract vehicle and no set-aside provisions were specified. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania to support the Agency's medical supply needs.</p>
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,064.90 delivery order contract is for the supply of Nateglinide 120 mg tablets, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of October 19, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of pharmaceutical products, primarily Januvia 100 mg tablets, to the Defense Logistics Agency (DLA). The contract, valued at $3,789.07, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 28, 2021. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award is for the delivery of NATEGLINIDE 60 MG TABLET UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,084.64 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of PIOGLITAZONE HCL 45 MG TABLET 500S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $3,038.78, was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a Firm Fixed Price Delivery Order contract with a completion date of March 20, 2023. The contract is not set aside for any specific business designation. Amerisourcebergen Drug Corp is a major...